NANOMATERIALS
NANOMATERIALS
批准号:
8360241
负责人:
ALEXANDER V KABANOV
金额:
$14.87万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2012-06-30
关键词:
Animal ModelAtomic Force MicroscopyBiocompatible MaterialsCell LineDrug Delivery SystemsFluorescence SpectroscopyFundingGrantLaboratoriesMeasurementMicellesNanotechnologyNational Center for Research ResourcesNebraskaNucleic AcidsPaclitaxelPharmaceutical PreparationsPrincipal InvestigatorProteinsResearchResearch InfrastructureResearch PersonnelResourcesSafetySmall Interfering RNASourceTechniquesTransmission Electron MicroscopyUnited States National Institutes of Healthcatalasecopper zinc superoxide dismutasecostlight scatteringnanocarriernanomaterialsnanomedicinenanoscalezeta potential
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
This core will serve three functions. First, it will develop nanoscale materials for drug delivery for each of projects. This will include new nanocarriers for drug, protein and nucleic acids delivery and include catalase nanozymes (Project 1) and copper-zinc superoxide dismutase nanozymes (Project 2), paclitaxel polymeric micelles (Project 3), and siRNA nanocarriers (Project 4).
Second, the core will integrate resources of the nanotechnology laboratories for a comprehensive and in-depth characterization of the nanomaterials. The combined characterization techniques include: static light scattering; dynamic light scattering; zeta-potential measurements; atomic force microscopy; transmission electron microscopy; and fluorescence spectroscopy.
Third, the core will evaluate safety of all new synthesized nanomaterials using respective cell lines and animal models, and will provide all investigators with controlled and standardized materials for biological use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
-
批准号:10790660
-
项目类别:
-
资助金额:$42.76万
-
财政年份:2023
-
负责人:ALEXANDER V KABANOV
-
依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10436355
-
项目类别:
-
资助金额:$60.08万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10684815
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10621403
-
项目类别:
-
资助金额:$11.79万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Diversity Supplement - TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10529457
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10306113
-
项目类别:
-
资助金额:$61.31万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
2017 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar
-
批准号:9260177
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2017
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Targeted Magneto-Mechanic Nanotherapeutics for Cancer
-
批准号:9382042
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2017
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Targeted Magneto-Mechanic Nanotherapeutics for Cancer
-
批准号:9751229
-
项目类别:
-
资助金额:$11.38万
-
财政年份:2017
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Nasal Leptin - Polymer Conjugate for Treatment of Obesity
-
批准号:9140512
-
项目类别:
-
资助金额:$21.58万
-
财政年份:2016
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:10650745
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:8934892
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Nanoformulation of the BDNF for treatment of stroke
-
批准号:9139992
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
-
批准号:8991307
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:10024629
-
项目类别:
-
资助金额:$46.71万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:10452492
-
项目类别:
-
资助金额:$42.13万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
-
批准号:9206144
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:10212976
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
NEW HIRES
-
批准号:8360242
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2011
-
负责人:ALEXANDER V KABANOV
-
依托单位:
NEBRASKA CENTER FOR NANOMEDICINE ADMINISTRATIVE CORE
-
批准号:8360236
-
项目类别:
-
资助金额:$66.62万
-
财政年份:2011
-
负责人:ALEXANDER V KABANOV
-
依托单位:
海外基金